International Journal of Stem Cells : eISSN 2005-5447

Fig. 3.

Download original image
Fig. 3. SLE disease-activated serum treatment in differentiated CMs. (a) Schematic diagram of procedures used in this study. (b) CCK-8 assay of CMs with and without serum treatment. (c) Expression of CM-specific markers TNNT2 and MYH6. (d) Expression of fibrosis marker, COL2A1. (e) Expression of hypertrophy marker, BNP. In each graph, the sample was n=3. (f) Fluorescence recording of calcium flux from HC-CMs and SLE-CMs treatment SLE serum. Scale bar indicates 200 μm.
International Journal of Stem Cells 2022;15:233-46 https://doi.org/10.15283/ijsc21158
© 2021 International Journal of Stem Cells